Navigation Links
Next-Generation Hemostatic Dressing Available for Military Emergencies
Date:7/21/2009

HemCon offers revolutionary, easy to use Z-Folded design with antibacterial effectiveness.

Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, Inc., today announced the launch of the ChitoGauze™ dressing platform. ChitoGauze is a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care use and is proven effective on severe, arterial bleeding. The initial product design received FDA 510(k) clearance in April 2009 and is available immediately for the military medical market in a 4 inch by 4 yard flexible and conforming gauze dressing.

From the creators of the hemostatic HemCon® Bandages, saving lives on the battlefield since 2003, comes a uniquely formulated chitosan impregnated gauze dressing. Designed to offer the latest in battlefield care requirements, this hemostatic dressing is formed in a unique z-folded pleat making delivery from package to wound easier and quicker than with a rolled product. "The dynamic stresses of combat operations can create an environment that is often overwhelming for battlefield care providers. A product that is not only highly effective, but is also easily employed is paramount. A simple modification such as making your package easy to open, or a z-folded dressing rather than rolled, can save a medic precious time which translates to saving lives," said former U.S. Army Medic Christopher Murphy, now of Wake Forest University. HemCon states that in addition to the z-fold, the dressing will ship by Fall 2009 with a packaging configuration that can be opened from any angle to offer easier, more rapid and sterile deployment. "Over our long and strong relationship with the U.S. Army, HemCon has teamed with military medical professionals to understand the latest field requirements and deliver what is needed. It's our mission to continue to help keep our soldiers coming home. Through the launch of the ChitoGauze platform, we're able to provide a critical, safe dressing that saves lives," said Bill Block, President of HemCon, U.S. and former U.S. Army Ranger.

The unique formulation of hemostatic ChitoGauze also offers antibacterial properties which provide medical professionals a multi-layered solution to help avoid infection. "As a physician, there's a great deal to consider when treating a wound - whether you are on the battlefield or in the ER. Having an antibacterial, protective layer provides an element of defense I want my patients to have," said Sudip Bose, MD, FACEP, FAAEM, attending Emergency Physician and former Major, U.S. Army. In testing, ChitoGauze demonstrated antibacterial properties against a wide range of microorganisms, including MRSA, VRE and Acinetobacter Baumannii.

HemCon's proprietary manufacturing process and the natural, unique characteristics of chitosan together create the ChitoGauze mechanism of action which slows blood movement through the dressing, offering a local hemostatic solution. The chitosan in ChitoGauze, without the addition of pro-clotting agents, binds red blood cells and platelets on the dressing's surface which provides localized clotting, independently from the normal clotting cascade. Localized clotting mitigates risk of emboli formation which can be found through the use of pro-clotting agents2.
www.hemcon.com

About HemCon Medical Technologies Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances, including Lyophilized Human Plasma and NanospiderTM technologies. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit www.hemcon.com.

1 Data from the ChitoGauze FDA submission is available for review from HemCon Medical Technologies, Inc.
2 Studies conducted by Prof. John Whitelock, University of New South Wales, in conjunction with an Australian ARC Linkage Grant.

###

Read the full story at http://www.prweb.com/releases/medical_products/Hemostatic_Dressing/prweb2662004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Next-Generation Hemostatic Dressing Available for Military Emergencies
2. Nonin Medical Announces FDA Clearance for its Next-Generation Regional Oximetry System
3. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
4. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
5. Abbott Announces Launch of Next-Generation Embolic Protection System
6. Purity Products Partners with Leading Vitamin D Expert to Create Next-Generation D3 Complex
7. Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
8. First heart patients implanted with next-generation mechanical heart pump
9. SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care
10. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
11. Parata Adopts Smart Service for Next-Generation Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Next-Generation Hemostatic Dressing Available for Military Emergencies
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... IN (PRWEB) , ... August 18, 2017 , ... Inc. ... annual list, the most prestigious ranking of the nation's fastest-growing private companies. This marks ... the exclusive Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 percent ...
(Date:8/18/2017)... ... ... “Dangerous Inheritance”: a mystery about saving the family farm. “Dangerous Inheritance” is ... she was raised on a farm. As Diane wrote this story, she used ... and mantra of ‘neighbors helping neighbors’ have always been a large part of her ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... and PETACH TIKVAH, Israel , ... BCLI), a leading developer of adult stem cell technologies ... quarter ending June 30, 2017. ... preparing for our pivotal Phase 3 trial to investigate ... , President and Chief Executive Officer of BrainStorm. "We ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
Breaking Medicine Technology: